The DOI matches its Crossref record; 128 of the 131 references it cites were found in a registry or an index.
Reprogramming of serine, glycine and one-carbon metabolism in cancer
Open accessAbstract
Metabolic pathways leading to the synthesis, uptake, and usage of the nonessential amino acid serine are frequently amplified in cancer. Serine encounters diverse fates in cancer cells, including being charged onto tRNAs for protein synthesis, providing head groups for sphingolipid and phospholipid synthesis, and serving as a precursor for cellular glycine and one-carbon units, which are necessary for nucleotide synthesis and methionine cycle reloading. This review will focus on the participation of serine and glycine in the mitochondrial one-carbon (SGOC) pathway during cancer progression, with an emphasis on the genetic and epigenetic determinants that drive SGOC gene expression. We will discuss recently elucidated roles for SGOC metabolism in nucleotide synthesis, redox balance, mitochondrial function, and epigenetic modifications. Finally, therapeutic considerations for targeting SGOC metabolism in the clinic will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One-carbon metabolism (1CM) is commonly dysregulated in cancer due to its contribution to core cellular building blocks (e.g., purine and pyrimidine nucleotides), epigenetics, post-translational modifications (PTMs), and redox homeostasis, and it is comprised of a complex network of enzymes.”
From A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Samanta, D., Park, Y., Andrabi, S. A., Shelton, L. M., Gilkes, D. M., & Semenza, G. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0530 · Cited by 242
RetractedWu, S., Zhang, G., Li, P., Chen, S., Zhang, F., Li, J., Jiang, C., Chen, X., Wang, Y., Du, Y., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4369-z · Cited by 51
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative Stress
Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M. A., Sadri, N., Yun, C., Popko, B., Paules, R. S., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00105-9 · Cited by 3,336
One-Carbon Metabolism in Health and Disease
Ducker, G. S., & Rabinowitz, J. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.009 · Cited by 2,239
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Cited by
Sorted by citations
A bacterial pan-genome makes gene essentiality strain-dependent and evolvable
Rosconi, F., Rudmann, E., Li, J., Surujon, D., Anthony, J. S., Frank, M. W., Jones, D. S., Rock, C. O., Rosch, J. W., Johnston, C. D., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01208-7 · Cited by 122
Pranzini, E., Pardella, E., Muccillo, L., Leo, A., Nesi, I., Santi, A., Parri, M., Zhang, T., Uribe, A. H., Lottini, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111233 · Cited by 106
Regulatory mechanisms of one-carbon metabolism enzymes
Petrova, B., Maynard, A. G., Wang, P., & Kanarek, N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105457 · Cited by 103
Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers
Sun, W. Y., Liu, R., Gao, X., Lin, Z., Tang, H., Cui, H., & Zhao, E. (2023) · Biomarker Research · doi:10.1186/s40364-023-00487-4 · Cited by 83
Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer
DeBlasi, J. M., & DeNicola, G. M. (2020) · Cancers · doi:10.3390/cancers12103023 · Cited by 82
Li, S., Hong, Y., Wan, L., Liu, J.-Y., Ren, L., Yang, Y., Ge, B., Zhang, Y., Fu, W.-Q., Zheng, X., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00894-7 · Cited by 61
A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight
Cuthbertson, C. R., Arabzada, Z., Bankhead, A., Kyani, A., & Neamati, N. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00223 · Cited by 57
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression
Tomecka, P., Kunachowicz, D., Górczyńska, J., Gebuza, M., Kuźnicki, J., Skinderowicz, K., & Choromańska, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168972 · Cited by 62
Metabolomics and the Multi-Omics View of Cancer
Wishart, D. S. (2022) · Metabolites · doi:10.3390/metabo12020154 · Cited by 57
Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
Wang, S., Xiaoxue, Y., Guanbin, S., Yang, L., Junyu, J., & Liu, W. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.05.007 · Cited by 47
Target enzymes in serine‐glycine‐one‐carbon metabolic pathway for cancer therapy
Sun, W. Y., Zhao, E., & Cui, H. (2022) · International Journal of Cancer · doi:10.1002/ijc.34353 · Cited by 39
Amino acid metabolism in glioblastoma pathogenesis, immune evasion, and treatment resistance
Srivastava, S., Anbiaee, R., Houshyari, M., Laxmi, L., Sridhar, S. B., Ashique, S., Hussain, M. S., Kumar, S., Taj, T., Akbarnejad, Z., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03721-1 · Cited by 34
Zhang, W., Bai, Y., Hao, L., Zhao, Y., Zhang, L., Ding, W., Qi, Y., & Xu, Q. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae121 · Cited by 32
Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
Tramonti, A., Cuyàs, E., Encinar, J. A., Pietzke, M., Paone, A., Verdura, S., Arbusà, A., Martı́n-Castillo, B., Giardina, G., Joven, J., et al. (2021) · Cancers · doi:10.3390/cancers13164009 · Cited by 31
The Ubiquitin–Proteasome System in Tumor Metabolism
Wang, J., Xiang, Y., Fan, M., Fang, S., & Hua, Q. (2023) · Cancers · doi:10.3390/cancers15082385 · Cited by 32
The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment
Zhou, X., Tian, C., Cao, Y., Zhao, M., & Wang, K. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1084609 · Cited by 32
Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic Significance
Stouras, I., Vasileiou, M., Kanatas, P., Tziona, E., Tsianava, C., & Theocharis, S. (2023) · Cells · doi:10.3390/cells12232686 · Cited by 29
Chu, C., Liu, S., Nie, L., Hu, H., Liu, Y., & Yang, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116305 · Cited by 28
Metabolic reprogramming in cancer: signaling pathways and therapeutic targets
Dong, S., & Lei, X. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02582-0 · Cited by 31
Biochemical Mechanisms Associating Alcohol Use Disorders with Cancers
Rodriguez, F. D., & Coveñas, R. (2021) · Cancers · doi:10.3390/cancers13143548 · Cited by 27
Hamano, M., Tomonaga, S., Osaki, Y., Oda, H., Kato, H., & Furuya, S. (2020) · Nutrients · doi:10.3390/nu12103018 · Cited by 25
Yang, Y., Huangfu, L., Li, H., & Yang, D. (2023) · International Journal of Hyperthermia · doi:10.1080/02656736.2023.2270654 · Cited by 24
Mechanism underlying circRNA dysregulation in the TME of digestive system cancer
Wu, Z., Yu, X., Zhang, S., He, Y., & Guo, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951561 · Cited by 22
Xie, S.-Y., Shi, D., Ouyang, Y. Q., Cheng, X.-Y., Chen, X., Jiang, T., Xia, W., Guo, L., & Lin, H. (2021) · Research Square · doi:10.21203/rs.3.rs-1016628/v1 · Cited by 22
Asparagine: A key metabolic junction in targeted tumor therapy
Wang, X., Gong, W., Xiong, X., Jia, X., & Xu, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107292 · Cited by 22
Wang, Y., Gan, X., Cheng, X., Jia, Y., Wang, G., Tang, X., Du, H., Li, X., Liu, X., Xing, X., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1754 · Cited by 21
Liu, N., Shi, F., Yang, L., Liao, W., & Cao, Y. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188724 · Cited by 22
Sun, S., Li, C., Cui, K., Liu, B., Zhou, M., Cao, Y., Zhang, J., Bian, Z., Fei, B., & Huang, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.770006 · Cited by 21
PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway
Duan, X., Chen, Y., Zhang, K., Chen, W., Zhao, J., Dai, X., Cao, W., Dong, Z., Mo, S., & Lü, J. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110736 · Cited by 20
Larriba, E., Sánchez‐García, A. B., Martínez‐Andújar, C., Albacete, A. A., & Pérez‐Pérez, J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810112 · Cited by 19
The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism
Tu, R., Ma, J., Zhang, P., Kang, Y., Xiong, X., Zhu, J., Li, M., & Zhang, C. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02524-y · Cited by 24
Aging impairs CD8 T cell responses in adoptive T-cell therapy against solid tumors
Kadyrzhanova, G., Tamai, M., Sarkar, S., Kalra, R. S., & Ishikawa, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1484303 · Cited by 18
Chen, L., Kang, Y., Jiang, Y., You, J., Huang, C.-T., Xu, X., & Chen, F. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154031 · Cited by 18
Folate Metabolism in Hepatocellular Carcinoma. What Do We Know So Far?
Quevedo-Ocampo, J., Escobedo-Calvario, A., Souza-Arroyo, V., Miranda-Labra, R. U., Bucio-Ortiz, L., Gutiérrez-Ruíz, M., Chávez-Rodríguez, L., & Gómez-Quiroz, L. (2022) · Technology in Cancer Research and Treatment · doi:10.1177/15330338221144446 · Cited by 17
HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression
Yang, Y., Zhang, M., Zhao, Y., Deng, T., Zhou, X. Y., Qian, H., Wang, M., Zhang, C., Huo, Z., Mao, Z., et al. (2023) · Cancer Science · doi:10.1111/cas.15982 · Cited by 19
Protein lipoylation in cancer: metabolic reprogramming and therapeutic potential
Li, S., Liu, Y., Hu, W., Deng, A., Ren, X., Chen, L., Lu, Y., Wu, Y., Huang, H., Cao, J., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02718-z · Cited by 17
Interplay between mTOR and Purine Metabolism Enzymes and Its Relevant Role in Cancer
Allegrini, S., Camici, M., Garcia‐Gil, M., Pesi, R., & Tozzi, M. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126735 · Cited by 17
Zhang, Y., Gong, R., Liu, Y., Sun, X., Liang, J., Zhou, Y., Wang, Y., Yu, W., Wang, Y., Tang, L., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.842406 · Cited by 16
Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells
Wang, K., Lu, Y., Li, H., Zhang, J., Ju, Y., & Ouyang, M. (2024) · Cancer Cell International · doi:10.1186/s12935-023-03194-0 · Cited by 16
Metabolic reprograming of cancer as a therapeutic target
Furukawa, T., Tabata, S., Minami, K., Yamamoto, M., Kawahara, K., & Tanimoto, A. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130301 · Cited by 15
Hussain, S. A., Sarker, M. I. M., Liu, Y., & Jin, T. Z. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020566 · Cited by 16
Kim, J., Lee, H., Choi, H., & Min, H. (2023) · Metabolites · doi:10.3390/metabo13040477 · Cited by 15
Sasaki, M., Yamamoto, K., Ueda, T., Irokawa, H., Takeda, K., Sekine, R., Itoh, F., Tanaka, Y., Kuge, S., & Shibata, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-38142-5 · Cited by 14
Sliusar, M. Y., Minchenko, D. O., Khita, O. O., Tsymbal, D. O., Viletska, Y. M., Luzina, O. Y., Danilovskyi, S. V., Ratushna, O. O., & Minchenko, О. H. (2023) · Endocrine Regulations · doi:10.2478/enr-2023-0028 · Cited by 14
Kong, W., Wang, Z., Chen, N., Mei, Y., Li, Y., & Yue, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.914332 · Cited by 14
Nazari, A., Osati, P., Fakhr, S. S., Faghihkhorasani, F., Ghanaatian, M., Faghihkhorasani, F., Rezaei‐Tazangi, F., Far, N. P., Shourideh, A., Ebrahimi, N., et al. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0491 · Cited by 13
Causal associations between liver traits and Colorectal cancer: a Mendelian randomization study
Ni, Y., Wang, W., Liu, Y., & Jiang, Y. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01755-w · Cited by 13
The enzymes of serine synthesis pathway in cancer metastasis
Li, L., Qin, Y., & Chen, Y. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119697 · Cited by 13
PSAT1 promotes the progression of colorectal cancer by regulating Hippo-YAP/TAZ-ID1 axis via AMOT
Tang, M., Song, K., Xie, D., Yuan, X., Wang, Y., Li, Z., Lu, X., Guo, L., Zhu, X., Xiong, L., et al. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05194-8 · Cited by 13
Zhong, H., Pan, R., Ouyang, Y., Xiao, T., Gu, W., Yang, H., Wang, H., Li, H., Peng, T., & Chen, P. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02571-3 · Cited by 13
SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
Situ, Y., Zhang, J., Liao, W., Liang, Q., Lu, L., Xu, Q., Chen, J., Lu, X., Cui, Y., Shao, Z., et al. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2809196 · Cited by 12
Dong, Y., Chen, Y., Wang, Y., Zhao, X., Zi, R., Hao, J., Ding, Q., Jiang, H., Wang, X., Lu, F., et al. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101330 · Cited by 12
Current status of cancer starvation therapy
Li, J., Dandan, T. O. N. G., & Lin, J. (2022) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2021-0297 · Cited by 12
Du, J., Huang, Y., Jing, S., Pei, Y., Qian, Y., & Zeng, Y. (2022) · Translational Cancer Research · doi:10.21037/tcr-21-2485 · Cited by 12
ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis
Gao, Y., Feng, L., Zhang, L., Geng, J., & Zhang, E. (2022) · Disease Markers · doi:10.1155/2022/7527996 · Cited by 13
Vital role of SHMT2 in diverse disease
Ma, W., Liu, R., Zhao, K., & Zhong, J. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.05.108 · Cited by 11
Ye, J., Huang, X., Tian, S., Wang, J., Wang, H., Feng, H., Zhao, X., Cao, S., Xuan, Y., Li, X., et al. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.113977 · Cited by 11
Self-citationMinchenko, О. H., Sliusar, M. Y., Khikhlo, Y. P., Halkin, O. V., Viletska, Y. M., Khita, O. O., & Minchenko, D. O. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110104 · Cited by 11
The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process
Majumder, A., Bano, S., & Nayak, K. B. (2024) · Biomolecules · doi:10.3390/biom14111387 · Cited by 11
Luque-Urbano, M. R., Fernández‐Ramos, D., Lopitz‐Otsoa, F., de Juan, V. G., Bizkarguenaga, M., Castro-Espadas, L., Hermoso-Martínez, U., Barbier‐Torres, L., Lu, S. C.-L., Millet, Ó., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100794 · Cited by 11
The role and research progress of serine metabolism in tumor cells
Lyu, H., Bao, S., Cai, L., Wang, M., Liu, Y., Sun, Y., & Hu, X. S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1509662 · Cited by 13
Talarico, M. C. R., Derchain, S., da Silva, L. F., Sforça, M. L., Rocco, S. A., Cardoso, M. R., & Sarian, L. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168639 · Cited by 10
Olawuni, B., & Bode, B. P. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00316.2024 · Cited by 10
Dai, W., Xie, D., Huang, H., Li, J., Guo, C., Cao, F., Yang, L., Zhong, C., & Liu, S. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101173 · Cited by 12
Dong, Y., Jin, F., Wang, J., Li, Q., Huang, Z., Xia, L., & Yang, M. (2023) · Current Gene Therapy · doi:10.2174/1566523223666230724121515 · Cited by 11
Ghini, V., Sorbi, F., Fambrini, M., & Magherini, F. (2024) · Cells · doi:10.3390/cells13080661 · Cited by 10
YY2/PHGDH axis suppresses tumorigenesis by inhibiting tumor cell de novo serine biosynthesis
Li, J., Luo, X., Wei, M., Li, Z., Li, Y., Zhao, H., Miyagishi, M., Kasim, V., & Wu, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115006 · Cited by 9
Minchenko, О. H., Sliusar, M. Y., Khita, O. O., Minchenko, D. O., Viletska, Y. M., Halkin, O. V., Levadna, L. O., Cherednychenko, A. A., & Khikhlo, Y. P. (2024) · Endocrine Regulations · doi:10.2478/enr-2024-0010 · Cited by 9
Karoii, D. H., Abroudi, A. S., Forghani, N., Bavandi, S., Djamali, M., Baghaei, H., Shafaeitilaki, S., & HasanZadeh, E. (2025) · Discover Oncology · doi:10.1007/s12672-025-01926-4 · Cited by 9
Targeting amino acid in tumor therapy
Ge, M., Xu, Y., Cui, L., Huang, E., Liu, Z., & Yin, K. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1582116 · Cited by 8
Huang, Y.-J., Chen, H., Jiang, Y., Meng, Z., She, C., Miao, Z., & Fan, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120716 · Cited by 8
Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
Zhang, J., Bai, J., Chen, G., Wang, J., Cheng, Y., Zhao, J., & Xiong, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1184626 · Cited by 8
Zhou, S., Cui, J., & Shi, Y. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040179 · Cited by 8
Su, S.-W., Chen, X., Wang, G., Li, P., Yang, T., Fang, K.-W., Wu, J., & Li, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-58618-2 · Cited by 8
Yang, Z., Zhang, Q., Luo, H., Shao, L., Liu, R., Kong, Y., Zhao, X., Geng, Y., Li, C., & Wang, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.601620 · Cited by 8
Cellular Signaling of Amino Acid Metabolism in Prostate Cancer
Yao, P., Cao, S., Zhu, Z., Wen, Y., Guo, Y., Liang, W., & Xie, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020776 · Cited by 7
Leão, L. Q. D. S., de Andrade, J. C., Marques, G. M., Guimarães, C. C., de Albuquerque, R. D. F. V., Silva, A. S. E., de Araujo, K. P., de Oliveira, M. P., Gonçalves, A. F., Figueiredo, H. F., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120346 · Cited by 7
Minchenko, О. H., Sliusar, M. Y., Khita, O. O., Viletska, Y. M., Luzina, O. Y., Danilovskyi, S. V., & Minchenko, D. O. (2024) · Endocrine Regulations · doi:10.2478/enr-2024-0016 · Cited by 6
Li, M., Deng, F., Dong, L., Wang, X., Jiang, H., Yao, S., Chen, Y., Duan, L., Du, H., Qin, G., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109398 · Cited by 6
Zhu, J., Li, S., Li, X., Wang, L., & Ling-bin, D. (2025) · Environmental Technology & Innovation · doi:10.1016/j.eti.2025.104242 · Cited by 4
Recent progress in serine metabolism reprogramming in tumors and strategies for serine deprivation
Liu, H., & Liu, Y. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1669565 · Cited by 4
Fang, S., Jin, G., Yan, M., Song, Y., Zhao, S., Zhang, C., Shao, Y. W., Zhao, K., Liu, M., Wang, Z., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2525213123 · Cited by 4
Wang, K., Lin, X., Wang, T., Zhang, X., Cheng, W., Xu, F., Wang, L., Li, B., Wang, M., Wang, W., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115195 · Cited by 4
Liu, C., Liu, T., Wei, Y., Shi, J., Deng, L., Song, M., & Shi, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1507125 · Cited by 3
Longitudinal serum metabolomics predicts therapeutic outcome in acute myeloid leukemia
Cai, Q., Liu, W., Yan, C., Li, J., Huang, Y., Li, X. O., Yang, Q., Wei, X., Yang, H., Zhang, G., et al. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102567 · Cited by 3
Xu, R., Jung, H., Choueiry, F., Zhang, S., Pearlman, R., Hampel, H., Jin, N. Y., Li, J., & Zhu, J. (2025) · iMetaOmics. · doi:10.1002/imo2.70003 · Cited by 3
Pan, K., Zhao, X., & Xu, W. (2022) · PubMed Central · doi:10.22074/cellj.2022.8046 · Cited by 3
Expression, Prognostic Value, and Immune Infiltration of MTHFD Family in Bladder Cancer
Zheng, B. S., Wang, S. D., Zhang, J., & Ge, C. G. (2023) · Current Cancer Drug Targets · doi:10.2174/1568009623666230804152603 · Cited by 3
Zhao, Y., Chang, Z., Hu, B., Zhang, Q., Zhang, D., He, C., Guo, Y., Peng, Z., Chen, C., & Chen, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1090542 · Cited by 3
Dörner, C., Steinbinder, J., Sachslehner, A. P., Sukseree, S., & Eckhart, L. (2025) · Metabolites · doi:10.3390/metabo15090601 · Cited by 2
Meng, H., Xiao, Z., Wang, Q., Li, D., & Li, Z. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02034-8 · Cited by 2
Ren, R., Fan, T., Li, Y., Li, C., Jin, F., Gao, H. Y., Wang, X., Xu, Y., Li, X., Li, S., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148112 · Cited by 2
Zhai, Z., Yang, F., Feng, R., Zhang, H., Wang, J., Zuo, H., Yang, X., Ye, M., Xu, H., Hu, J., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.034 · Cited by 2
Доценко, О. И., & Shtofel, D. K. (2020) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-020-00949-8 · Cited by 2
HER2-low Breast Cancer: Salivary Metabolic Features and Therapeutic Perspectives
Bel’skaya, L. V. (2025) · Frontiers in Bioscience-Scholar · doi:10.31083/fbs36652 · Cited by 2
SFXN3 is a Prognostic Marker and Promotes the Growth of Acute Myeloid Leukemia
Jin, F., He, L., Wang, J., Zhang, Y., & Yang, M. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01326-5 · Cited by 2
Metabolic Reprogramming in Kidney Cancer: Implications for Therapy
Edo, E. T. (2025) · annals of urologic oncology · doi:10.32948/auo.2025.06.02 · Cited by 2
Metabolic Rewiring in Cancer: Understanding the Complexity of Metabolic Networks
Sharma, A., Negi, N., Sharma, I., & Sobti, R. C. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_27 · Cited by 1
Yu, Q., Li, N., Bao, P., Huang, C., Zheng, Q., Wang, T., Ma, C., Deng, J., Jiang, F., Jia, J., et al. (2025) · Animals · doi:10.3390/ani15192929 · Cited by 2
Multifunctionality analysis of serine hydroxymethyltransferases from human and Escherichia coli
Hayashi, M., Sakai‐Kato, K., & Miyamoto, T. (2025) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2025.141107 · Cited by 1
Metadata
- Authors
- Li, A. M., & Ye, J.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Ye, Jiangbin
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 1866
- Issue
- 10
- Pages
- 165841
- ISSN
- 0925-4439 (ISSN-L)
- PMC
- PMC7442608
- OpenAlex
- W3026201556
- Cited by
- 127
- References
- 131
- Citations by year
- 2026: 17 · 2025: 28 · 2024: 28 · 2023: 25 · 2022: 17 · 2021: 8 · 2020: 4
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mary Kay Foundation
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Keywords
- serine metabolism, glycine metabolism, one-carbon metabolism, cancer metabolism, nucleotide synthesis, methionine cycle, redox homeostasis, mitochondrial function, epigenetic modifications, epigenetic regulation
- MeSH terms
- Animals, Carbon, Glycine, Humans, Methionine, Mitochondria, Neoplasms, Protein Processing, Post-Translational, Serine, Transcription Factors, Metabolic Networks and Pathways, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review